SIROCTID 0.05 mg/ml, solution for injection or concentrate for solution for infusion in a pre-filled syringe 6 syringes of 1 ml
Active ingredients: Octreotide acetate, Octreotide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection or infusion6 syringes of 1 mlintraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SIROCTID 0,05 mg/ml, solution injectable ou solution à diluer pour perfusion en seringue préremplie
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 6 seringue(s) préremplie(s) en verre de 1 ml avec aiguille(s)
- Marketing authorisation holder
- CHEMI (ITALIE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Apr 2011
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65490897CIP73953545CIP133400939535456Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACÉTATE D'OCTRÉOTIDEsolution | — | SA |
| OCTRÉOTIDEsolution | 50 microgrammes · 1 ml de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.